Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Hologic Inc Add to portfolio

INX:HOLX, Aug 20, 04:48 UTC

Latest INX:HOLX News

Filter your feed

Apply Filter

Thursday, August 15


News

Hologic, Inc. (NASDAQ:HOLX) Stake Lessened by Aviva PLC – Riverton Roll

HOLX

Aviva PLC cut its stake in Hologic, Inc. (NASDAQ:HOLX) by 2.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). SevenBridge Financial Group LLC now owns 1,205 shares of the medical equipment provider’s stock worth $58,000 after buying an additional 762 shares in the last quarter. In other Hologic news, insider Peter J. Valenti III sold 4,545 shares of the stock in a transaction that occurred on Monday, June 3rd. Piper Jaffray Companies raised their target price on shares of Hologic from $49.00 to $59.00 and gave the stock an “overweight” rating in a report on Thursday, August 1st.

Read Full Details

Topics:
  • Business
  • Financial

Monday, August 12


News

Parnassus Investments Position in Hologic INC (HOLX) Upped by $4.84 Million

HOLX

Parnassus Investments Position in Hologic INC (HOLX) Upped by $4.84 Million. 253.74 million shares or 1.48% less from 257.56 million shares in 2018Q4 were reported. Moreover, Sterling Management Ltd Liability has 0.65% invested in Hologic, Inc. (NASDAQ:HOLX) for 1.35 million shares. Teachers Retirement Systems Of The State Of Kentucky holds 0.08% of its portfolio in Hologic, Inc. (NASDAQ:HOLX) for 139,761 shares.

Read Full Details

Topics:
  • Business
  • Financial

Sunday, August 11


News

Hologic, Inc. (NASDAQ:HOLX) Receives Consensus Recommendation of “Hold” from Analysts – Riverton Roll

HOLX

Shares of Hologic, Inc. (NASDAQ:HOLX) have been assigned an average recommendation of “Hold” from the sixteen ratings firms that are covering the company, MarketBeat reports. Needham & Company LLC lowered their target price on shares of to $10.00 and set a “buy” rating on the stock in a research note on Wednesday, July 10th. In related news, insider Peter J. Valenti III sold 4,545 shares of the firm’s stock in a transaction dated Monday, June 3rd. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. As a group, analysts predict that Hologic will post 2.42 earnings per share for the current fiscal year.

Read Full Details

Topics:
  • Business
  • Financial
News

Hologic, Inc. (NASDAQ:HOLX) Position Cut by Daiwa Securities Group Inc. – Tech Know Bits

HOLX

Daiwa Securities Group Inc. decreased its position in shares of Hologic, Inc. (NASDAQ:HOLX) by 2.8% during the second quarter, according to the company in its most recent filing with the SEC. The stock has a market cap of $13.38 billion, a P/E ratio of 22.45, a P/E/G ratio of 2.27 and a beta of 0.74. The medical equipment provider reported $0.63 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.61 by $0.02. Zacks Investment Research raised shares of Hologic from a “hold” rating to a “buy” rating and set a $46.00 price objective on the stock in a report on Wednesday, May 29th.

Read Full Details

Topics:
  • Business
  • Financial
News

As Hologic INC (HOLX) Stock Rose, Osterweis Capital Management INC Has Cut Holding by $7.56 Million

HOLX

It dived, as 36 investors sold HOLX shares while 141 reduced holdings. 253.74 million shares or 1.48% less from 257.56 million shares in 2018Q4 were reported. Olstein Capital Mgmt Limited Partnership has 0.49% invested in Hologic, Inc. (NASDAQ:HOLX). Asset Mgmt Inc invested in 0.02% or 24,479 shares. More interesting news about Hologic, Inc. (NASDAQ:HOLX) were released by: Nasdaq.com and their article: “GNC Holdings (GNC) Q2 Earnings Beat Estimates, Margins Expand – Nasdaq” published on July 29, 2019 as well as Seekingalpha.com‘s news article titled: “Minerva prevails in Hologic appeal of patent ruling – Seeking Alpha” with publication date: July 24, 2019.

Read Full Details

Topics:
  • Business
  • Financial

Saturday, August 10


News

Global Skin Rejuvenation Devices Market 2019-2024 By Key Players Cutera, Hologic, Lutronic, Syneron Medical, Lumenis, Strata Skin Sciences – Market Reports

HOLX

Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. Any special requirements about this report, please let us know and we can provide custom report. Chapter Three: Analysis of Global Key Manufacturers 3.1 Cutera 3.1.1 Company Profile 3.1.2 Product Information 3.1.3 2014-2019 Production Information 3.1.4 Contact Information 3.2 Hologic 3.2.1 Company Profile 3.2.2 Product Information 3.2.3 2014-2019 Production Information 3.2.4 Contact Information 3.3 Lutronic 3.2.1 Company Profile 3.3.2 Product Information 3.3.3 2014-2019 Production Information 3.3.4 Contact Information 3.4 Syneron Medical 3.4.1 Company Profile 3.4.2 Product Information 3.4.3 2014-2019 Production Information 3.4.4 Contact Information 3.5 Lumenis 3.5.1 Company Profile 3.5.2 Product Information 3.5.3 2014-2019 Production Information 3.5.4 Contact Information 3.6 Strata Skin Sciences 3.6.1 Company Profile 3.6.2 Product Information 3.5.3 2014-2019 Production Information 3.6.4 Contact Information 3.7 BISON MEDICAL 3.7.1 Company Profile 3.7.2 Product Information 3.7.3 2014-2019 Production Information 3.7.4 Contact Information 3.8 Company H 3.8.1 Company Profile 3.8.2 Product Information 3.8.3 2014-2019 Production Information 3.8.4 Contact Information …… ……. Chapter Ten: Proposals for New Project 10.1 Market Entry Strategies 10.2 Countermeasures of Economic Impact 10.3 Marketing Channels 10.4 Feasibility Studies of New Project Investment.

Read Full Details

Topics:
  • Business
  • Financial
  • Science

Thursday, August 08


News

Global Hepatitis Test Kits Market 2019 Industry Growth, Size, Trends, Share, Opportunities and Forecast to 2024: Bio-Rad Laboratories, Siemens, Roche, BioMerieux, Abbott Laboratories, Hologic, Qiagen, Creative Diagnostics, Meridian Bioscience – Market Analyst

HOLX SIE +1 more HOLX SIE ABT

Global Hepatitis Test Kits Market 2019 Industry Growth, Size, Trends, Share, Opportunities and Forecast to 2024: Bio-Rad Laboratories, Siemens, Roche, BioMerieux, Abbott Laboratories, Hologic, Qiagen, Creative Diagnostics, Meridian Bioscience. MarketResearchNest.com adds “Global Hepatitis Test Kits Market Growth 2019-2024” this market research report in its research database with Report Summary, Table of Content, Research Methodologies and Data Sources. A Hepatitis Test Kits Market provides an extensive view of size; trends and shape have been developed in this report to identify factors that will exhibit a significant impact in boosting the sales of Hepatitis Test Kits Market in the near future. New vendors in the Hepatitis Test Kits market are facing tough competition from established international vendors as they struggle with technological innovations, reliability and quality issues.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, August 07


News

Hologic Inc (HOLX) Chairman, President and CEO Stephen P Macmillan Sold $9.5 million of Shares

HOLX

Hologic Inc (HOLX) Chairman, President and CEO Stephen P Macmillan Sold $9.5 million of Shares. Chairman, President and CEO of Hologic Inc (30-Year Financial, Insider Trades) Stephen P Macmillan (insider trades) sold 194,396 shares of HOLX on 08/05/2019 at an average price of $48.77 a share. Hologic Inc develops, manufactures and supplies diagnostics products, medical imaging systems and surgical products for women's health. Hologic Inc has a market cap of $13.16 billion; its shares were traded at around $49.25 with and P/S ratio of 4.01.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Sunday, August 04


News

Hologic, Inc. (NASDAQ:HOLX) Stake Trimmed by Daiwa Securities Group Inc. – Trent Times

HOLX

FMR LLC now owns 13,264,384 shares of the medical equipment provider’s stock worth $641,996,000 after purchasing an additional 10,709,693 shares in the last quarter. Norges Bank purchased a new position in Hologic in the 4th quarter worth about $75,662,000. Zacks Investment Research raised Hologic from a “hold” rating to a “buy” rating and set a $46.00 price target on the stock in a research note on Wednesday, May 29th. In related news, insider Peter J. Valenti III sold 4,545 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The medical equipment provider reported $0.63 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.61 by $0.02.

Read Full Details

Topics:
  • Business
  • Financial

Friday, August 02


News

SuperSonic Imagine Announces the Settlement and Delivery of Hologic's Acquisition of Approximately 46% of Shares in SuperSonic Imagine and the Appointment of New Board Members

HOLX

SuperSonic Imagine (Euronext: SSI, FR0010526814, PEA-PME eligible, the "Company"), a company specialized in ultrasound medical imaging, announced today the settlement-delivery of the acquisition by Hologic Hub Ltd, a wholly-owned indirect subsidiary of Hologic, Inc., of approximately 46% of SuperSonic Imagine’s shares, pursuant to the acquisition agreement entered into on August 1, 2019 between Hologic and the Company's main shareholders (the “Acquisition Agreement”). The company designs, develops and markets an ultrasound platform whose exclusive ultrafast technology (UltraFast™) has given rise to new imaging methods, which have now become standards in the non-invasive care path for the characterization of breast, liver or prostate diseases. With more than 2,300 ultrasound platforms installed worldwide, SuperSonic Imagine is present in more than 80 countries and its main markets are China, the United States and France. SuperSonic Imagine is a company listed on Euronext (symbol: SSI). For more information, visit www.supersonicimagine.fr.

Read Full Details

Topics:
  • Business
  • Financial